NCT00450086View on ClinicalTrials.gov

Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis

PHASE3CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

June 30, 2011

Study Completion Date

August 31, 2011

Conditions
Collagenous Colitis
Interventions
DRUG

Budesonide

9 mg per day

DRUG

Mesalazine

3 g per day

DRUG

Placebo

0 g per day

Trial Locations (1)

20249

Center of digestive diseases, Hamburg

Sponsors
All Listed Sponsors
lead

Dr. Falk Pharma GmbH

INDUSTRY